New types of localization methods for adrenocorticotropic hormone-dependent Cushing's syndrome

R Senanayake, D Gillett, J MacFarlane… - Best Practice & …, 2021 - Elsevier
The management of endogenous Cushing's syndrome (CS) typically involves two key
steps:(i) confirmation of autonomous hypercortisolism and (ii) localization of the cause to …

Management of endocrine disease: pituitary 'incidentaloma': neuroradiological assessment and differential diagnosis

V Vasilev, L Rostomyan, AF Daly… - European journal of …, 2016 - academic.oup.com
Pituitary incidentalomas are a by-product of modern imaging technology. The term
'incidentaloma'is neither a distinct diagnosis nor a pathological entity. Rather, it is a …

[HTML][HTML] Brain inflammation and intracellular α-synuclein aggregates in macaques after SARS-CoV-2 infection

IH Philippens, KP Böszörményi, JAM Wubben… - Viruses, 2022 - mdpi.com
SARS-CoV-2 causes acute respiratory disease, but many patients also experience
neurological complications. Neuropathological changes with pronounced …

[HTML][HTML] Continuing Challenges in the Definitive Diagnosis of Cushing's Disease: A Structured Review Focusing on Molecular Imaging and a Proposal for Diagnostic …

TNA Slagboom, DJ Stenvers, E van de Giessen… - Journal of Clinical …, 2023 - mdpi.com
The definitive diagnosis of Cushing's disease (CD) in the presence of pituitary
microadenoma remains a continuous challenge. Novel available pituitary imaging …

Pituitary incidentaloma

SM Constantinescu, D Maiter - La Presse Médicale, 2021 - Elsevier
Pituitary incidentalomas (PI) are lesions of the pituitary region discovered fortuitously by
imaging for reasons unrelated to pituitary disease. They range from small cysts to large …

Advances in the imaging of pituitary tumors

J MacFarlane, WA Bashari… - Endocrinology and …, 2020 - endo.theclinics.com
Pituitary adenomas (PA) are typically benign, slow-growing tumors of the adenohypophysis,
which come to attention because of associated endocrine dysfunction (eg …

High-resolution18F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease

P Chittiboina, BK Montgomery, C Millo… - Journal of …, 2015 - thejns.org
OBJECT High-resolution PET (hrPET) performed using a high-resolution research
tomograph is reported as having a resolution of 2 mm and could be used to detect …

Management of incidental pituitary findings on CT, MRI, and 18F-fluorodeoxyglucose PET: A white paper of the ACR incidental findings committee

JK Hoang, AR Hoffman, RG González… - Journal of the American …, 2018 - Elsevier
Abstract The ACR Incidental Findings Committee presents recommendations for managing
pituitary findings that are incidentally detected on CT, MRI and 18 F-fluorodeoxyglucose …

Selective resection of cushing microadenoma guided by preoperative hybrid 18-fluoroethyl-L-tyrosine and 11-C-methionine PET/MRI

S Berkmann, M Roethlisberger, B Mueller… - Pituitary, 2021 - Springer
Abstract Purpose 11-C-methionine (MET)-positron emission tomography (PET) as an
adjunct to magnetic resonance imaging (MRI) has been proposed as a suitable molecular …

CRH stimulation improves 18F-FDG-PET detection of pituitary adenomas in Cushing's disease

J Boyle, NJ Patronas, J Smirniotopoulos, P Herscovitch… - Endocrine, 2019 - Springer
Objective In MRI-negative cases Cushing's disease (CD), surgeons perform a more
extensive exploration of the pituitary gland, with fewer instances of hormonal remission. 18 F …